Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI

Cowen is a Buyer of Express Scripts (ESRX) on Weakness

Cowen analyst Charles Rhyee is incrementally positive on Express Scripts (NASDAQ: ESRX) following the earnings call and would be buyers on today's weakness. The analyst reiterated an Outperform rating and price target of $83.

Rhyee sees limited downside risk as ANTM's contribution of... More

Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures

Morgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.

Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More

Pre-Open Stock Movers 04/25: (NORD) (APFH) (STRP) Higher; (CTRV) (ESRX) (TSLA) Lower (more...)

Today's Pre-Open Movers

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) 27% LOWER; announced the pricing of an underwritten public offering of common stock and warrants to purchase common stock, with anticipated gross proceeds of $12 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ContraVir. ContraVir is offering 12,000,000 shares of its common stock and warrants to purchase 6,000,000 shares of its common stock at a combined offering price of $1.00.

Nord Anglia Education, Inc. (NYSE: NORD) 18% HIGHER;... More

Express Scripts (ESRX) PT Lowered to $67 at Jefferies

Jefferies lowered its price target on Express Scripts (NASDAQ: ESRX) to $67.00 (from $88.00) while maintaining a Buy rating.

Analyst Brian Tanquilut raises FY 2017 EPS estimate from $1.32 to $1.33 and comments on Anthem (NYSE: ANTM) development: "we are... More

Express Scripts (ESRX): ANTM Loss Removes Overhang on Shares - Cowen

Cowen analyst, Charles Rhyee, reiterated his Outperform rating on shares of Express Scripts (NASDAQ: ESRX) but cut his price target to $83 after Anthem (NYSE: ANTM) announced its decision not to renew its agreement with ESRX. That said,... More

Express Scripts (ESRX) weekly volatility elevated, into contract with Anthem (ANTM) unlikely to be renewed

Express Scripts (ESRX) April weekly call option implied volatility is at 40, May weekly is at 27, May is at 23; compared to its 52-week range of 17 to 56 into reporting quarterly results and said that it is unlikely that its contract with Anthem (ANTM) will be renewed.

Bank Of America's Comments On Express Scripts (ESRX)

BofA/Merrill Lynch maintains Neutral on Express Scripts (NASDAQ: ESRX) price target of $77.00.

Analyst Steven Valiquette tells clients late Monday that he believes ESRX EPS run-rate without Anthem (NYSE: ANTM) was around $4.00 in 2016 and could be... More

Options expected to have increasing volume

Options expected to have increasing volume: ESRX ABX JBLU EAT AKS WHR NEM TMUS UIS SLCA AA

Express Scripts (ESRX) PT Lowered to $61 at Mizuho Securities

Mizuho Securities lowered its price target on Express Scripts (NASDAQ: ESRX) to $61.00 (from $76.00) while maintaining a Neutral rating.

Analyst Ann Hynes estimates the impact to ESRX in losing Anthem (NYSE: ANTM) may negatively impact ESRX... More

Express Scripts (ESRX) Says Anthem (ANTM) Intends to Move its Business

Express Scripts Holding Company (Nasdaq: ESRX) said its current long-term PBM contract with Anthem expires on December 31, 2019, and Anthem is currently engaged in a Request for Proposal (RFP) process for a PBM service provider following the end of its contract with Express Scripts. While the Company has not formally participated in the RFP process, in recent months, management for the Company and Anthem have had several conversations in which the Company proposed providing as much as $1 billion in annual value ($3 billion in the aggregate) in the form of price concessions for 2017-2019 in connection... More